SOPHiA GENETICS SA·4

Jul 7, 4:03 PM ET

Verma Abhimanyu 4

Research Summary

AI-generated summary

Updated

SOPHiA GENETICS (SOPH) CTO Abhimanyu Verma Sells 5,285 Shares

What Happened
Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS SA (SOPH), sold 5,285 shares on July 6, 2026 in an open-market transaction. The reported weighted-average sale price was $5.10 per share for proceeds of $26,957 (sales executed at prices ranging $4.97–$5.41). This was a sale to satisfy tax withholding and not a new equity purchase.

Key Details

  • Transaction date: July 6, 2026 (Form filed July 7, 2026).
  • Transaction type/code: Sale (S).
  • Shares sold: 5,285; weighted-average price: $5.10; total reported proceeds: $26,957.
  • Price range: shares were sold in multiple trades at $4.97 to $5.41 (footnote states the reporter can provide the per-price breakdown on request).
  • Reason/footnotes: Sold to satisfy tax withholding on RSU vestings on July 2 and July 3, 2026; transactions were executed under a pre-established Rule 10b5-1(c) trading plan and were non-discretionary (F1). (F2 explains the weighted-average price and price range.)
  • Shares owned after transaction: Not specified in the information provided in your summary.
  • Timeliness: Filed the day after the transaction (no late filing indicated in the provided details).

Context
These sales were routine tax-withholding dispositions tied to restricted stock unit vesting and executed under a 10b5-1 plan, which typically reflect pre-planned, non-discretionary activity rather than an ad hoc view on the company’s prospects. For further detail (exact number of shares sold at each price), the reporting person offers to provide the breakdown to the issuer, any shareholder, or the SEC staff upon written request.